Send mail to Author

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _     _____    __   __    _____     ______   __   __  
| |  | ||  |  ___||  \ \\/ //  |  ___||  /_____//  \ \\/ // 
| |/\| ||  | ||__     \   //   | ||__    `____ `    \ ` //  
|  /\  ||  | ||__     / . \\   | ||__    /___//      | ||   
|_// \_||  |_____||  /_//\_\\  |_____||  `__ `       |_||   
`-`   `-`  `-----`   `-`  --`  `-----`   /_//        `-`'   
                                         `-`
 


Back to frontdoor view

OPUS4 Logo